Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line

Biochemical and Biophysical Research Communications

Volumn 354, Issue 4, 2007, Pages 892-898

  Nakamura, Yohko ^a   Ozaki, Toshinori ^a   Niizuma, Hidetaka ^a   Ohira, Miki ^a   Kamijo, Takehiko ^a   Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Apoptosis; Cisplatin; Homozygous deletion; Neuroblastoma; p53

Indexed keywords

CISPLATIN; MUTANT PROTEIN; PROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; DNA BINDING; DNA DAMAGE; HOMOZYGOSITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEAR LOCALIZATION SIGNAL; OLIGOMERIZATION; PRIORITY JOURNAL; TERMINAL SEQUENCE; TRANSACTIVATION; WILD TYPE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DNA DAMAGE; GENE DELETION; HUMANS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846849373     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.057     Document Type: Article

References (26)

1. Hollstein M., Sidransky D., Vogelstein B., and Harris H. p53 mutations in human cancers. Science 253 (1991) 49-53
2. Levine A.J., Momand J., and Finlay C.A. The p53 tumour suppressor gene. Nature 351 (1991) 453-456
3. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
4. Vousden K.H., and Lu X. Live or let die: the cells response to p53. Nat. Rev. Cancer 2 (2002) 594-604
5. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
6. Kubbutat M.H.G., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
7. Shaulsky G., Goldfinger N., Ben-Ze'ev A., and Rotter V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10 (1990) 6565-6577
8. Liang S.H., Hong D., and Clarke M.F. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem. 273 (1998) 19817-19821
9. Vogan K., Bernstein M., Leclerc J.M., Brisson L., Brossard J., Brodeur G.M., Pelletier J., and Gros P. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53 (1993) 5269-5273
10. Moll U.M., LaQuaglia M., Benard J., and Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92 (1995) 4407-4411
11. Moll U.M., Ostermeyer A.G., Haladay R., Winkfield B., Frazier M., and Zambetti G. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16 (1996) 1126-1137
12. Ostermeyer A.G., Runko E., Winkfield B., Ahn B., and Moll U.M. Cytoplasmically sequestrated wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc. Natl. Acad. Sci. USA 93 (1996) 15190-15194
13. Nikolaev A.Y., Li M., Puskas N., Qin J., and Gu W. Parc: A cytoplasmic anchor for p53. Cell 112 (2003) 29-40
14. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., Hamilton G., Hindle A.K., Huey B., Kimura K., Law S., Myambo K., Palmer J., Yistra B., Yue J.P., Gray J.W., Jain A.N., Pinkel D., and Albertson D.G. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29 (2001) 263-264
15. Nigro J.M., Misra A., Zhang L., Smimov I., Colman H., Griffin C., Ozburn N., Chen M., Pan E., Koul D., Yung W.K., Feuerstein B.G., and Aldape K.D. Integrated array-comparative genomic hybridization and expression array profiles identity clinically relevant molecular subtypes of glioblastoma. Cancer Res. 65 (2005) 1678-1686
16. Coppock D.L., and Pardee A.B. Control of thymidine kinase mRNA during the cell cycle. Mol. Cell. Biol. 7 (1987) 2925-2932
17. Hamanaka R., Smith M.R., O'Connor P.M., Maloid S., Mihalic K., Spivak J.L., Longo D.L., and Ferris D.K. Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J. Biol. Chem. 270 (1995) 21086-21091
18. Kim I.S., Kim D.H., Han S.M., Chin M.U., Nam H.J., Cho H.P., Choi S.Y., Song B.J., Kim E.R., Bae Y.S., and Moon Y.H. Truncated form of importin α identified in breast cancer cell inhibits nuclear import of p53. J. Biol. Chem. 275 (2000) 23139-23145
19. Rodicker F., and Putzer B.M. p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement. Cancer Res. 63 (2003) 2737-2741
20. Knudsen K.E., Booth D., Naderi S., Sever-Chroneos Z., Fribourg A.F., Hunton C., Feramisco J.R., Wang J.Y.J., and Knudsen E.S. RB-dependent S-phase response to DNA damage. Mol. Cell. Biol. 20 (2000) 7751-7763
21. Hollstein M., Hergenhahn M., Yang Q., Bartsch H., Wang Z.Q., and Hainaut P. New approaches to understanding p53 gene tumor mutation spectra. Mutat. Res. 431 (1999) 199-209
22. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., and Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
23. Lomax M.E., Barnes D.M., Hupp T.R., Picksley S.M., and Camplejohn R.S. Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members. Oncogene 17 (1998) 643-649
24. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.L. p53 isoforms can regulates p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
25. Goldschneider D., Horvilleur E., Plassa L.F., Guillaud-Bataille M., Million K., Wittmer-Dupret E., Danglot G., de The H., Benard J., May E., and Douc-Rasy S. Expression of C-terminal deleted p53 isoforms in neuroblastoma. Nucleic Acids Res. 34 (2006) 5603-5612
26. Arai N., Nomura D., Yokota K., Wolf D., Brill E., Shohat O., and Rotter V. Immunologically distinct p53 molecules generated by alternative splicing. Mol. Cell. Biol. 6 (1986) 3232-3239